Page last updated: 2024-10-31

metyrapone and Empty Sella Syndrome

metyrapone has been researched along with Empty Sella Syndrome in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Empty Sella Syndrome: A condition when the SELLA TURCICA is not filled with pituitary tissue. The pituitary gland is either compressed, atrophied, or removed. There are two types: (1) primary empty sella is due a defect in the sella diaphragm leading to arachnoid herniation into the sellar space; (2) secondary empty sella is associated with the removal or treatment of PITUITARY NEOPLASMS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Menéndez Torre, EL1
López Carballo, MT1
Rodríguez Erdozain, R1
Urbieta Echezarreta, M1
Lafita Tejedor, J1
Forga Llenas, L1

Other Studies

1 other study available for metyrapone and Empty Sella Syndrome

ArticleYear
[ACTH-independent Cushing's syndrome due to bilateral macronodular adrenal hyperplasia with empty sella turcica and anterior panhypopituitarism].
    Revista clinica espanola, 1992, Volume: 190, Issue:5

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aged; Cushing Syndrome; Empty Sella Syndrome; Humans; H

1992